When will Hongyuan Pharmaceutical be listed?

Hongyuan Pharmaceutical (30 1246) was listed on March 20th, 2023, with 47,257,200 shares, each priced at 50 yuan. The company's main business is the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations. In the fourth quarter of 2022, the company's total assets reached 3.893 billion yuan, net assets were 265.438+0.32 billion yuan, and operating income was 2.064 billion yuan. Part of the funds raised by this IPO will be used for an annual output of 2.5 billion high-end preparation workshop projects, amounting to 290 million yuan; Antiviral APIs and intermediates project, with an amount of 206.8 million yuan; The project amount of R&D center and multifunctional experimental workshop is153.93 million yuan, with a total investment of 65 100 million yuan, and the actual raised funds are 2.363 billion yuan.